Mineralys Therapeutics MLYS
NASDAQ MLYS
$15.67 +0.15 (+0.97%)
As of: Nov 11, 2026 · 12:14 PM EST

Mineralys Therapeutics (MLYS) Shares Outstanding (Diluted) (2022 - 2026)

Updated

Mineralys Therapeutics (MLYS) posted Weighted Average Shares Outstanding (Diluted) of 88.99 million for Q3 2026, up 26.1% from 70.59 million a year earlier and up 5.0% from the prior quarter.

Analysis

Mineralys Therapeutics (MLYS) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends

For FY2025, Mineralys Therapeutics' Weighted Average Shares Outstanding (Diluted) came in at 67.66 million, up 39.4% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) has increased for three consecutive years, with a three-year compound annual growth rate of 135.7% (FY2022 to FY2025).
  • In prior years, Mineralys Therapeutics' Weighted Average Shares Outstanding (Diluted) was 48.54 million in FY2024 (+34.1%), 36.19 million in FY2023 (+600.3%) and 5.17 million in FY2022.
  • The Q3 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q1 2022.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased in each of the last 15 quarters, with growth averaging 34.7% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 18.4% in Q1 2025 to 671.6% in Q2 2023.
  • According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 84.73 million (Q2 2026), 82.83 million (Q1 2026) and 67.66 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Mineralys Therapeutics 1.37 Bn -1.21 Bn - 88.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 88.99 Mn
Jun 30, 2026 84.73 Mn
Mar 31, 2026 82.83 Mn
Dec 31, 2025 67.66 Mn
Sep 30, 2025 70.59 Mn
Jun 30, 2025 65.45 Mn
Mar 31, 2025 53.16 Mn
Dec 31, 2024 48.54 Mn
Sep 30, 2024 49.82 Mn
Jun 30, 2024 49.36 Mn
Mar 31, 2024 44.90 Mn
Dec 31, 2023 36.19 Mn
Sep 30, 2023 39.93 Mn
Jun 30, 2023 39.75 Mn
Mar 31, 2023 24.76 Mn
Dec 31, 2022 5.17 Mn
Sep 30, 2022 5.18 Mn
Jun 30, 2022 5.15 Mn
Mar 31, 2022 5.12 Mn
API Access

Mineralys Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=MLYS&period=max&api_key=YOUR_API_KEY